Next, FACS sorted CD133+ cells were treated with different concentrations resveratrol for 48 h, which indicated resveratrol significantly inhibited proliferation of osteosarcoma stem cells (CD133+ cells subpopulation) (Fig 2E). The gene discussed is PROM1; the disease is osteosarcoma.